Company profile
Teladoc Health, Inc.
NYSE: TDOC · Healthcare · Medical - Healthcare Information Services
PublicHQ Purchase, NYCIK 0001477449Reports USD
#101 of 1,418 Healthcare companies by revenue39th-percentile growth
EA Score
69BFH 64DQ 86GM 48SS 75
v0.1 · 65/100 weight · provisional
↑ filing timeliness, workforce scale · ↓ revenue growth (YoY), 3-yr revenue growth
Methodology →Revenue TTM
$2.5B
Rev growth YoY (TTM)
-1.5%
Net income (FY)
-$200.3M
Employees
5,600
as of 2026-08-09
Market cap
$1.3B
as of 2026-08-09
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$2.5B$2.5B2025
Net income-$200.3M-$200.3M2025
Operating income-$263.0M-$263.0M2025
Total assets$2.9B$2.9B2025
Liabilities$1.5B$1.5B2025
Equity$1.4B$1.4B2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY19
FY22
FY22
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Other100%
By geography
UNITED STATES82%
Non-US18%
The read
What is Teladoc Health, Inc.’s revenue?
Teladoc Health, Inc. booked $2.5B in FY2025 revenue, contracting 1.5% year over year — slower than 61% of Healthcare companies we track, at a -7.9% net margin.
Peers · Healthcare
Bio-Rad Laboratories, Inc.84B+Medpace Holdings, Inc.84B+Chemed Corporation89AAveanna Healthcare Holdings Inc.66BRoyalty Pharma plc72BHims & Hers Health, Inc.68BKey facts
CEOCharles Divita
SectorHealthcare
IndustryMedical - Healthcare Information Services
HeadquartersPurchase, NY
ExchangeNYSE: TDOC
Employees5,600
IPO date2015-06-30
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.